The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106781174 10678117 4 F 20160802 20141229 20160808 EXP CA-ROCHE-1514163 ROCHE 0.00 M Y 0.00000 20160808 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106781174 10678117 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 375 MG SOLUTION FOR INJECTION QOW
106781174 10678117 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 14 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 15 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 16 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 17 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 18 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 19 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 20 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 21 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 22 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 23 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION
106781174 10678117 24 SS XOLAIR OMALIZUMAB 1 Subcutaneous U UNKNOWN 103976 SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106781174 10678117 1 Asthma

Outcome of event

Event ID CASEID OUTC COD
106781174 10678117 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106781174 10678117 Asthma
106781174 10678117 Body temperature decreased
106781174 10678117 Chest discomfort
106781174 10678117 Cold sweat
106781174 10678117 Dizziness
106781174 10678117 Dyspnoea
106781174 10678117 Flatulence
106781174 10678117 Headache
106781174 10678117 Hypertension
106781174 10678117 Hypoventilation
106781174 10678117 Influenza
106781174 10678117 Injection site pain
106781174 10678117 Injection site swelling
106781174 10678117 Malaise
106781174 10678117 Oropharyngeal pain
106781174 10678117 Pain of skin
106781174 10678117 Respiratory rate increased
106781174 10678117 Weight decreased
106781174 10678117 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106781174 10678117 1 20120320 0
106781174 10678117 2 20120525 0
106781174 10678117 3 20120821 0
106781174 10678117 4 20120918 0
106781174 10678117 5 20121002 0
106781174 10678117 6 20130205 0
106781174 10678117 7 20130402 0
106781174 10678117 8 20130416 0
106781174 10678117 9 20130430 0
106781174 10678117 10 20130528 0
106781174 10678117 11 20131001 0
106781174 10678117 12 20131028 0
106781174 10678117 13 20131209 0
106781174 10678117 14 20140120 0
106781174 10678117 15 20140203 0
106781174 10678117 16 20140317 0
106781174 10678117 17 20140428 0
106781174 10678117 18 20140526 0
106781174 10678117 19 20140610 0
106781174 10678117 20 20140825 0
106781174 10678117 21 20141103 0
106781174 10678117 22 20141202 0
106781174 10678117 23 20141217 0
106781174 10678117 24 20150811 0